Methodological Developments for Magnetic Resonance Imaging (MRI)
NCT ID: NCT02887053
Last Updated: 2022-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1807 participants
INTERVENTIONAL
2008-11-30
2022-05-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimization of the Acquisition Sequence to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam
NCT04645628
Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis Methods
NCT02091518
Development of Protocols and Methods for Image Processing and Enhancement of Magnetic Resonance Imaging (MRI) Data.
NCT04942704
Development of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects
NCT05036629
Study of New Magnetic Resonance Methods
NCT00001844
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All subjects
All subjects will have an MRI examination
MRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* to be able to give an informed consent,
* to have underwent a pre-inclusion medical examination,
* to present no contraindication to MR examination,
* to be enrolled in a social security plan.
Exclusion Criteria
* subject under a measure of legal protection,
* any contraindication to MR examination (active medical device, ferromagnetic foreign body, pregnancy, morbid obesity, claustrophobia, … ).
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Valérie LAURENT
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valérie Laurent, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
CHRU de Nancy
Jacques Felblinger, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
CHRU de Nancy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Nancy
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-A01209-46
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.